These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32744396)

  • 1. Industry payments to Australian medical oncologists and clinical haematologists: a cross-sectional analysis of publicly available disclosures.
    Pokorny AMJ; Bero LA; Moynihan R; Mintzes BJ
    Intern Med J; 2021 Nov; 51(11):1816-1824. PubMed ID: 32744396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines.
    Mitchell AP; Mishra A; Dey P; Curry MA; Trivedi NU; Haddadin M; Rahman MW; Winn AN; Dusetzina SB; Bach PB
    Oncologist; 2021 Sep; 26(9):771-778. PubMed ID: 33982829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis.
    Ozaki A; Saito H; Onoue Y; Sawano T; Shimada Y; Somekawa Y; Tsuji A; Tanimoto T
    BMJ Open; 2019 Sep; 9(9):e028805. PubMed ID: 31494604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology.
    Mitchell AP; Winn AN; Lund JL; Dusetzina SB
    Oncologist; 2019 May; 24(5):632-639. PubMed ID: 30728276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing Financial Payments From Industry to Medical Oncologists in the United States, 2014-2017.
    Rahman MW; Trivedi NU; Bach PB; Mitchell AP
    J Natl Compr Canc Netw; 2021 Dec; 20(13):1-9. PubMed ID: 34965511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of Industry Payments to Radiation Oncologists in 2014 Using the Centers for Medicare and Medicaid Services Open Payments Database.
    Jairam V; Yu JB
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):19-26. PubMed ID: 26547386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions with the pharmaceutical industry and the practice, knowledge and beliefs of medical oncologists and clinical haematologists: a systematic review.
    Pokorny AMJ; Fabbri A; Bero LA; Moynihan R; Mintzes BJ
    Br J Cancer; 2022 Jan; 126(1):144-161. PubMed ID: 34599297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Industry payments to US physicians for cancer therapeutics: An analysis of the 2016-2018 open payments datasets.
    Meyers DE; Chisamore TM; McInnes MDF; Gyawali B; Prasad V; Booth CM
    J Cancer Policy; 2021 Jun; 28():100283. PubMed ID: 35559912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.
    Saito H; Ozaki A; Sawano T; Shimada Y; Tanimoto T
    JAMA Netw Open; 2019 Apr; 2(4):e192834. PubMed ID: 31026027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financial Disclosures Reported by Industry Among Authors of the American Academy of Ophthalmology Clinical Practice Guidelines.
    Nguyen AX; Joly-Chevrier M; Nguyen DD; Wu AY
    JAMA Ophthalmol; 2023 Apr; 141(4):378-383. PubMed ID: 36928457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conflict of interest disclosure in orthopaedic and general surgical trauma literature.
    Tisherman RT; Couch BK; Reddy RP; Tisherman SA; Shaw JD
    Injury; 2021 Aug; 52(8):2148-2153. PubMed ID: 33812702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conflict of interest among Italian medical oncologists: a national survey.
    DeCensi A; Numico G; Ballatori E; Artioli F; Clerico M; Fioretto L; Livellara V; Ruggeri B; Tomirotti M; Verusio C; Roila F;
    BMJ Open; 2018 Jun; 8(6):e020912. PubMed ID: 29961019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Industry Payments to Medical Oncologists in the United States Since the Inception of the Open Payments Program, 2014 to 2019.
    Tarras ES; Marshall DC; Rosenzweig K; Korenstein D; Chimonas S
    JAMA Oncol; 2021 Mar; 7(3):440-444. PubMed ID: 33377904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy Between AJSM Author-Reported Disclosures and the Centers for Medicare and Medicaid Services Open Payments Database.
    Boddapati V; Fu MC; Nwachukwu BU; Ranawat AS; Zhen WY; Dines JS
    Am J Sports Med; 2018 Mar; 46(4):969-976. PubMed ID: 29382212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions with industry under the Sunshine Act: an example from gynecologic oncology.
    Shalowitz DI; Spillman MA; Morgan MA
    Am J Obstet Gynecol; 2016 Jun; 214(6):703-7. PubMed ID: 26902988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and Patterns of Industry-Related Payments to Oncologists in 2014.
    Marshall DC; Moy B; Jackson ME; Mackey TK; Hattangadi-Gluth JA
    J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27389914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of physicians receiving large payments from pharmaceutical companies and the accuracy of their disclosures in publications: an observational study.
    Norris SL; Holmer HK; Ogden LA; Burda BU; Fu R
    BMC Med Ethics; 2012 Sep; 13():24. PubMed ID: 23013260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Industry Relationships With Medical Oncologists: Who Are the High-Payment Physicians?
    Wright K; Meyers DE; Chisamore TM; McInnes MDF; Sismondo S; Gyawali B; Prasad V; Booth CM
    JCO Oncol Pract; 2022 Jul; 18(7):e1164-e1169. PubMed ID: 35696634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical Industry Payments to Medical Oncologists in the Netherlands: Trends and Patterns Provided by an Open-Access Transparency Data Set.
    Schnog JB; Samson MJ; Gersenbluth I; Duits AJ
    JCO Oncol Pract; 2024 Jun; 20(6):843-851. PubMed ID: 38354335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of financial relationships between Japanese certified pediatric hematologist/oncologists and pharmaceutical companies: a cross-sectional analysis of personal payments from pharmaceutical companies between 2016 and 2019.
    Kamamoto S; Murayama A; Kusumi E; Yoshida M; Saito H; Sawano T; Yamashita E; Tanimoto T; Ozaki A
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29891. PubMed ID: 35949170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.